Can Chinese companies that allegedly fixed prices for U.S. customers deflect liability by saying they acted at their government's behest? Jurors may get a chance to answer that question beginning Monday, when an antitrust class action trial against a group of Chinese vitamin manufacturers opens in U.S. district court in Brooklyn.
Chinese Vitamin Makers Head to Trial for Alleged Price-Fixing
The Litigation Daily
February 22, 2013
This article requires premium access
This article requires premium access to The AmLaw Litigation Daily. Please sign in or subscribe to read the full text.